Clinical Trials Browser

Recruiting × Rhabdomyosarcoma × Irinotecan × Clear all

NCT04796012 2026-04-16

VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors

Phase 1/2 Recruiting

Rhabdomyosarcoma

NCT06541262 2026-04-09

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Phase 1/2 Recruiting

Liposarcoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

NCT04625907 2024-05-23

FaR-RMS

Phase 1/2 Recruiting

Rhabdomyosarcoma